查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941439

出血性和缺血性中風治療設備市場規模、佔有率和趨勢分析報告：按治療方法、最終用途、地區和細分市場預測，2026-2033年

Hemorrhagic & Ischemic Stroke Treatment Devices Market Size, Share & Trends Analysis Report By Treatment (Aneurysm & Hemorrhagic Stroke Interventions, Ischemic Stroke Interventions ), By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 220 Pages | 商品交期: 2-10個工作天內

價格

出血性和缺血性中風治療設備市場概述

全球出血性和缺血性中風治療設備市場預計在 2025 年達到 38 億美元，預計到 2033 年將達到 62.4 億美元。

預計從 2026 年到 2033 年，該市場將以 6.42% 的年複合成長率（CAGR）成長。推動該市場成長的因素包括全球中風負擔加重、人口老化以及高血壓和糖尿病等危險因子的盛行率上升。

微創血管內治療方法的日益普及，以及器械安全性、精準性和臨床療效的提升，正在推動市場需求的成長。此外，綜合卒中中心的擴建和快速診療路徑的建立，也促進了先進卒中治療技術的更廣泛應用。

隨著出血性中風發病率的不斷上升，未來幾年對出血性中風治療設備的需求預計將顯著成長。世界卒中組織發布的《2025年全球卒中概況》顯示，每年新增卒中病例超過1200萬例，預計全球約四分之一的人一生中會經歷卒中。報告也指出，出血性中風的負擔十分沉重，其中腦出血（ICH）佔所有中風病例的28.8%，蜘蛛網膜下腔出血（SAH）佔5.8%。預計該疾病盛行率的不斷上升將成為預測期內推動市場成長的主要因素。

在預測期內，對微創治療策略（包括早期微創腦出血清除術和內視鏡血腫清除術）的日益重視預計將成為市場成長的主要驅動力。此外，正在進行的臨床試驗也支持技術發展，以提高手術安全性和臨床療效。例如，2024年4月，Niko公司公佈了ENRICH（早期微創腦出血清除術）臨床試驗的正面結果。 Niko公司採用BrainPath Myriad系統進行的早期微創旁束手術（MIPS）安全有效，且療效優於目前腦出血的標準治療方案－基於指引的藥物治療。

研究機構、學術中心和產業相關人員進行的臨床試驗數量不斷增加，是出血性中風治療器械市場的主要驅動力。這些試驗產生的臨床證據檢驗了微創和新一代技術的安全性和有效性，從而支持監管部門的核准和臨床醫生的信心。此外，這些試驗也推動了創新，拓展了治療適應症，加速了先進器材的推廣和商業化，推動了市場的持續成長。

神經血管介入器材技術的快速發展預計將在推動市場擴張方面發揮關鍵作用。業內相關人員正致力於開發和商業化下一代解決方案，以提高手術的精準性、安全性和治療效果。此外，器械設計、材料和影像相容性等方面的創新，也使臨床醫生能夠更有效率地處理複雜病例，從而進一步促進市場成長。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 出血性和缺血性中風治療設備市場變數、趨勢和範圍

  • 市場譜系展望
    • 母市場展望
    • 相關及輔助市場展望
  • 市場動態
  • 出血性和缺血性中風治療設備市場分析工具
    • 波特分析
    • PESTEL 分析

第4章 出血性和缺血性中風治療設備市場：按治療方式分類的估算和趨勢分析

  • 全球出血性和缺血性中風治療器械市場：按治療方法分類的差異分析（2025 年和 2033 年）
  • 全球出血性和缺血性中風治療設備市場規模及趨勢分析（依治療方法分類，2021-2033年）
  • 動脈瘤和出血性中風的治療
  • 缺血性中風治療（機械性重組）
    • 血栓摘取支架系統
    • 抽吸血栓切除系統
  • 腦血管成形術和血管重塑
    • 球囊血管成形術系統
    • 顱內和頸動脈支架置入系統
    • 線圈輔助裝置（球囊輔助/支架輔助）
  • 輔助和手術用途的接入設備
    • 引導管和遠端通路導管
    • 微導管
    • 檢修鞘套和電線

第5章 出血性和缺血性中風治療設備市場：按最終用途分類的估算和趨勢分析

  • 全球出血性和缺血性中風治療設備市場：按最終用途分類的變化分析（2025 年和 2033 年）
  • 全球出血性和缺血性中風治療設備市場規模及趨勢分析（按最終用途分類，2021-2033年）
  • 醫院
  • 專業神經外科中心
  • 門診手術中心

第6章 出血性和缺血性中風治療設備市場：按地區分類的估算和趨勢分析

  • 區域儀錶板
  • 市場規模及趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 2025年企業市場占有率分析
  • 公司熱力圖分析
  • 策略規劃
    • 業務拓展
    • 併購
    • 夥伴關係與合作
    • 引入新的治療方法
    • 研究與開發
    • 公司簡介
    • Medtronic
    • MicroVention, Inc. (Terumo Corporation)
    • Balt
    • Scientia Vascular, Inc.
    • MicroPort Scientific Corporation
    • Johnson & Johnson (MedTech)
    • phenox GmbH (Wallaby Medical)
    • Acandis GmbH
    • B. Braun SE
    • Integra LifeSciences
    • Infinity Neuro LLC
    • Penumbra, Inc.
    • Boston Scientific Corporation
    • Stryker
    • Peter LAZIC GmbH
    • Vesalio Inc.
Product Code: GVR-4-68040-843-2

Hemorrhagic & Ischemic Stroke Treatment Devices Market Summary

The global hemorrhagic & ischemic stroke treatment devices market size was estimated at USD 3.80 billion in 2025 and is projected to reach USD 6.24 billion by 2033, growing at a CAGR of 6.42% from 2026 to 2033. The market is driven by the rising global burden of stroke, aging populations, and increasing prevalence of risk factors such as hypertension and diabetes.

Growing adoption of minimally invasive endovascular procedures, along with improvements in device safety, precision, and clinical outcomes, is accelerating demand. In addition, the expansion of comprehensive stroke centers and the development of faster treatment pathways are supporting the wider utilization of advanced stroke treatment technologies.

The rising incidence of hemorrhagic strokes is expected to significantly increase demand for hemorrhagic stroke treatment devices over the coming years. According to the Global Stroke Fact Sheet 2025 published by the World Stroke Organization, more than 12 million new stroke cases occur annually, and nearly one in four people worldwide will experience a stroke during their lifetime. The report indicates that intracerebral hemorrhage (ICH) accounts for 28.8% and subarachnoid hemorrhage (SAH) for 5.8% of all incident strokes, underscoring the substantial hemorrhagic stroke burden. The growing prevalence of this disease is anticipated to be a key factor supporting market growth during the forecast period.

The increasing focus on minimally invasive treatment strategies, including early minimally invasive evacuation of intracerebral hemorrhage (ICH) and endoscopic hematoma removal, is expected to be a key driver of market growth over the forecast period. Furthermore, ongoing clinical trials are supporting the development of technologies that improve procedural safety and clinical outcomes. For instance, in April 2024, NICO Corporation reported positive results from the ENRICH (Early MiNimally-invasive Removal of ICH) clinical trial, showing that early minimally invasive parafascicular surgery (MIPS) using its BrainPath and Myriad systems was safe and demonstrated superior outcomes compared with guideline-based medical management alone, the current standard of care for ICH.

The increasing volume of clinical trials conducted by research institutions, academic centers, and industry players is a key driver of the hemorrhagic stroke treatment devices market. These trials generate clinical evidence that validates the safety and effectiveness of minimally invasive and next-generation technologies, supporting regulatory approvals and clinician confidence. In addition, they facilitate innovation, expand treatment indications, and accelerate the adoption and commercialization of advanced devices, thereby driving sustained market growth.

The rapid advancement of neurovascular device technology is expected to play a crucial role in driving market expansion. Industry participants are focusing on developing and commercializing next-generation solutions that improve procedural accuracy, safety, and treatment effectiveness. In addition, innovations such as enhanced device design, improved materials, and better imaging compatibility are helping clinicians manage complex cases more efficiently, further supporting market growth.

Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemorrhagic & ischemic stroke treatment devices market report based on treatment, end use, and region:

  • Treatment Outlook (Revenue, USD Million, 2021 - 2033)
  • Aneurysm & Hemorrhagic Stroke Interventions
    • By Indication
    • Intracranial Aneurysm
    • cSDH (MMA Embolization)
    • AVM & AVF Embolization
    • By Device
    • Embolization Coiling Systems
    • Bare Platinum Coils
    • Coated / Bioactive Coils
    • Flow Diversion Systems
    • Standard Flow-Diverting Stents (e.g., Pipeline)
    • Next-Generation / Surface-Modified Flow Diverters
    • Intrasaccular Flow Disruption Devices
    • Woven EndoBridge (WEB)
    • Contour Neurovascular System
    • Luna Aneurysm Embolization System
    • Liquid Embolization Agents
    • Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)
    • Adhesive Liquid Embolics (NBCA)
  • Ischemic Stroke Interventions (Mechanical Revascularization)
    • Stent Retriever Systems
    • Aspiration-Based Thrombectomy Systems
  • Cerebral Angioplasty & Vascular Remodeling
    • Balloon Angioplasty Systems
    • Intracranial & Carotid Stenting Systems
    • Coil-Assisted Adjunctive Devices (Balloon-assisted and stent-assisted)
  • Ancillary & Procedural Access Devices
    • Guiding & Distal Access Catheters
    • Microcatheters
    • Access Sheaths & Wires
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Neurosurgery Centers
  • Ambulatory Surgical Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Sweden
    • Denmark
    • Norway
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Treatment
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising burden of hemorrhagic stroke
      • 3.2.1.2. Growing focus on minimally invasive procedures
      • 3.2.1.3. Technological advancements in neurovascular devices
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of devices and procedures
      • 3.2.2.2. Product recalls
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing emphasis on R&D expansion
      • 3.2.3.2. Rising public awareness about hemorrhagic stroke
      • 3.2.3.3. Increasing clinical trials
      • 3.2.3.4. Increasing launches of devices for ischemic stroke treatment
      • 3.2.3.5. Expansion opportunities in emerging markets
      • 3.2.3.6. Rising stroke incidence among younger adults
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Complications associated with neurovascular treatments
      • 3.2.4.2. Limited skilled professionals
  • 3.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market: Treatment Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Size & Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
  • 4.4. Aneurysm & Hemorrhagic Stroke Interventions
    • 4.4.1. Aneurysm & hemorrhagic stroke interventions market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. By indication
      • 4.4.2.1. By indication market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Intracranial aneurysm
        • 4.4.2.2.1. Intracranial aneurysm market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. cSDH (MMA Embolization)
        • 4.4.2.3.1. cSDH (MMA Embolization) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.4. AVM & AVF embolization
        • 4.4.2.4.1. AVM & AVF embolization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. By device
      • 4.4.3.1. By device market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Embolization coiling systems
        • 4.4.3.1.1. Embolization coiling systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Flow diversion systems
        • 4.4.3.2.1. Flow diversion systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Intrasaccular flow disruption devices
        • 4.4.2.3.1. Intrasaccular flow disruption devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. Liquid embolization agents
        • 4.4.3.4.1. Liquid embolization agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Ischemic Stroke Interventions (Mechanical Revascularization)
    • 4.5.1. Ischemic stroke interventions (Mechanical Revascularization) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Stent retriever systems
      • 4.5.2.1. Stent retriever systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Aspiration-based thrombectomy systems
      • 4.5.3.1. Aspiration-based thrombectomy systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Cerebral Angioplasty & Vascular Remodeling
    • 4.6.1. Cerebral angioplasty & vascular remodeling market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Balloon angioplasty systems
      • 4.6.2.1. Balloon angioplasty systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Intracranial & carotid stenting systems
      • 4.6.3.1. Intracranial & carotid stenting systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted)
      • 4.6.4.1. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Ancillary & procedural access devices
    • 4.7.1. Ancillary & procedural access devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Guiding & distal access catheters
      • 4.7.2.1. Guiding & distal access catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Microcatheters
      • 4.7.3.1. Microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Access sheaths & wires
      • 4.7.4.1. Access sheaths & wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hemorrhagic & Ischemic Stroke Treatment Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market: End use Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Specialty Neurosurgery Centers
    • 5.5.1. Specialty neurosurgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ambulatory Surgical Centers
    • 5.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Regional Estimates & Trend Analysis by Treatment, and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. North America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. UK hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. Germany hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. France hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Italy hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Spain hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Denmark hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Competitive scenario
      • 6.4.9.3. Regulatory framework
      • 6.4.9.4. Reimbursement scenario
      • 6.4.9.5. Norway hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. China hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Japan hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. India hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. South Korea hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Australia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Competitive scenario
      • 6.5.7.3. Regulatory framework
      • 6.5.7.4. Reimbursement scenario
      • 6.5.7.5. Thailand hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Brazil hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Argentina hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Middle East and Africa
    • 6.7.1. Middle East and Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. South Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. Saudi Arabia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. UAE hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Kuwait hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis, 2025
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Treatment Launches
    • 7.5.5. Research And Development
    • 7.5.6. Company Profiles
    • 7.5.7. Medtronic
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Treatment Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. MicroVention, Inc. (Terumo Corporation)
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Treatment Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Balt
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Treatment Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Scientia Vascular, Inc.
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Treatment Benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. MicroPort Scientific Corporation
      • 7.5.11.1. Company overview
      • 7.5.11.2. Financial performance
      • 7.5.11.3. Treatment Benchmarking
      • 7.5.11.4. Strategic initiatives
    • 7.5.12. Johnson & Johnson (MedTech)
      • 7.5.12.1. Company overview
      • 7.5.12.2. Financial performance
      • 7.5.12.3. Treatment Benchmarking
      • 7.5.12.4. Strategic initiatives
    • 7.5.13. phenox GmbH (Wallaby Medical)
      • 7.5.13.1. Company overview
      • 7.5.13.2. Financial performance
      • 7.5.13.3. Treatment Benchmarking
      • 7.5.13.4. Strategic initiatives
    • 7.5.14. Acandis GmbH
      • 7.5.14.1. Company overview
      • 7.5.14.2. Financial performance
      • 7.5.14.3. Treatment Benchmarking
      • 7.5.14.4. Strategic initiatives
    • 7.5.15. B. Braun SE
      • 7.5.15.1. Company overview
      • 7.5.15.2. Financial performance
      • 7.5.15.3. Treatment Benchmarking
      • 7.5.15.4. Strategic initiatives
    • 7.5.16. Integra LifeSciences
      • 7.5.16.1. Company overview
      • 7.5.16.2. Financial performance
      • 7.5.16.3. Treatment Benchmarking
      • 7.5.16.4. Strategic initiatives
    • 7.5.17. Infinity Neuro LLC
      • 7.5.17.1. Company overview
      • 7.5.17.2. Financial performance
      • 7.5.17.3. Treatment Benchmarking
      • 7.5.17.4. Strategic initiatives
    • 7.5.18. Penumbra, Inc.
      • 7.5.18.1. Company overview
      • 7.5.18.2. Financial performance
      • 7.5.18.3. Treatment Benchmarking
      • 7.5.18.4. Strategic initiatives
    • 7.5.19. Boston Scientific Corporation
      • 7.5.19.1. Company overview
      • 7.5.19.2. Financial performance
      • 7.5.19.3. Treatment Benchmarking
      • 7.5.19.4. Strategic initiatives
    • 7.5.20. Stryker
      • 7.5.20.1. Company overview
      • 7.5.20.2. Financial performance
      • 7.5.20.3. Treatment Benchmarking
      • 7.5.20.4. Strategic initiatives
    • 7.5.21. Peter LAZIC GmbH
      • 7.5.21.1. Company overview
      • 7.5.21.2. Financial performance
      • 7.5.21.3. Treatment Benchmarking
      • 7.5.21.4. Strategic initiatives
    • 7.5.22. Vesalio Inc.
      • 7.5.22.1. Company overview
      • 7.5.22.2. Financial performance
      • 7.5.22.3. Treatment Benchmarking
      • 7.5.22.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 4 North America hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 6 U.S. hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 8 Canada hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 10 Mexico hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Europe hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 12 Europe hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 13 Europe hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Germany hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 15 Germany hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16 UK hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 17 UK hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 18 France hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 19 France hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Italy hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 21 Italy hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Spain hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 23 Spain hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Denmark hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 25 Denmark hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Sweden hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 27 Sweden hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Norway hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 29 Norway hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 32 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 33 China hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 34 China hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Japan hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 36 Japan hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 37 India hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 38 India hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 40 South Korea hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Australia hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 42 Australia hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Thailand hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 44 Thailand hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 45 Latin America hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 46 Latin America hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 47 Latin America hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Brazil hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 49 Brazil hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Argentina hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 51 Argentina hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 52 MEA hemorrhagic & ischemic stroke treatment devices market, by region, 2021 - 2033 (USD Million)
  • Table 53 MEA hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 54 MEA hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 55 South Africa hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 56 South Africa hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 59 UAE hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 60 UAE hemorrhagic & ischemic stroke treatment devices market, by application, 2021 - 2033 (USD Million)
  • Table 61 UAE hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Kuwait hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021 - 2033 (USD Million)
  • Table 63 Kuwait hemorrhagic & ischemic stroke treatment devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hemorrhagic & ischemic stroke treatment devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Hemorrhagic & ischemic stroke treatment devices - market size and growth prospects (USD Million)
  • Fig. 11 Hemorrhagic & ischemic stroke treatment devices market: Industry Value Chain Analysis
  • Fig. 12 Hemorrhagic & ischemic stroke treatment devices market: Market Dynamics
  • Fig. 13 Hemorrhagic & ischemic stroke treatment devices market: PORTER's Analysis
  • Fig. 14 Hemorrhagic & ischemic stroke treatment devices market: PESTEL Analysis
  • Fig. 15 Hemorrhagic & ischemic stroke treatment devices market share by treatment, 2025 & 2033 (USD Million)
  • Fig. 16 Hemorrhagic & ischemic stroke treatment devices market, by treatment: market share, 2023 & 2030
  • Fig. 17 Aneurysm & hemorrhagic stroke interventions market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 By indication market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Intracranial aneurysm market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 cSDH (MMA Embolization) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 AVM & AVF embolization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 By device market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Embolization coiling systems market share by application, 2025 & 2033 (USD Million)
  • Fig. 24 Bare platinum coils market share by application, 2025 & 2033 (USD Million)
  • Fig. 25 Coated / bioactive coils market share by application, 2025 & 2033 (USD Million)
  • Fig. 26 Flow diversion systems market share by application, 2025 & 2033 (USD Million)
  • Fig. 27 Standard flow-diverting stents (eg, pipeline) market share by application, 2025 & 2033 (USD Million)
  • Fig. 28 Next-generation / surface-modified flow diverters market share by application, 2025 & 2033 (USD Million)
  • Fig. 29 Intrasaccular flow disruption devices market share by application, 2025 & 2033 (USD Million)
  • Fig. 30 Woven endobridge (WEB) market share by application, 2025 & 2033 (USD Million)
  • Fig. 31 Luna aneurysm embolization system market share by application, 2025 & 2033 (USD Million)
  • Fig. 32 Liquid embolization agents market share by application, 2025 & 2033 (USD Million)
  • Fig. 33 Non-adhesive liquid embolics (onyx, squid, PHIL) market share by application, 2025 & 2033 (USD Million)
  • Fig. 34 Adhesive liquid embolics (NBCA) market share by application, 2025 & 2033 (USD Million)
  • Fig. 35 Ischemic stroke interventions (mechanical revascularization) market share by application, 2025 & 2033 (USD Million)
  • Fig. 36 Stent retriever systems market share by application, 2025 & 2033 (USD Million)
  • Fig. 37 Aspiration-based thrombectomy system market share by application, 2025 & 2033 (USD Million)
  • Fig. 38 Cerebral angioplasty & vascular remodeling market share by application, 2025 & 2033 (USD Million)
  • Fig. 39 Balloon angioplasty systems market share by application, 2025 & 2033 (USD Million)
  • Fig. 40 Intracranial & carotid stenting systems market share by application, 2025 & 2033 (USD Million)
  • Fig. 41 Coil-assisted adjunctive devices (balloon-assisted and stent-assisted) market share by application, 2025 & 2033 (USD Million)
  • Fig. 42 Ancillary & procedural access devices market share by application, 2025 & 2033 (USD Million)
  • Fig. 43 Guiding & distal access catheters market share by application, 2025 & 2033 (USD Million)
  • Fig. 44 Microcatheters market share by application, 2025 & 2033 (USD Million)
  • Fig. 45 Access sheaths & wires market share by application, 2025 & 2033 (USD Million)
  • Fig. 46 Hemorrhagic & ischemic stroke treatment devices market share by end use, 2025 & 2033 (USD Million)
  • Fig. 47 Hemorrhagic & ischemic stroke treatment devices market, by end use: market share, 2023 & 2030
  • Fig. 48 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 49 Specialty neurosurgery centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 50 Ambulatory surgical centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 51 Regional marketplace: key takeaways
  • Fig. 52 North America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 US hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Canada hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Mexico hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Europe hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 UK hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Germany hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 France hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Italy hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Spain hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Sweden hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Denmark hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Norway hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific hemorrhagic & ischemic stroke treatment devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 China hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Japan hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 India hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 South Korea hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Australia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Thailand hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Latin America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Brazil hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Argentina hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 MEA hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 UAE hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Kuwait hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key company categorization
  • Fig. 81 Company market positioning
  • Fig. 82 Key company market share analysis, 2025
  • Fig. 83 Strategic framework